D-0622-2016 Class II Terminated

Recalled by Sentara Enterprises — Chesapeake, VA

FDA drug recall D-0622-2016 was initiated by Sentara Enterprises on September 18, 2015 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Product sterility cannot be guaranteed. The recall status is terminated (terminated June 29, 2016). Affected quantity: a) 7 Bags, b) 4 Bags.

Recall Details

Product Type
Drugs
Report Date
February 3, 2016
Initiation Date
September 18, 2015
Termination Date
June 29, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 7 Bags, b) 4 Bags

Product Description

DOBUTAMINE HCL in D5W, Packaged as a) 240MG in 60ML Homepumps and b) 1520MG in 380ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.

Reason for Recall

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Distribution Pattern

U.S. Including: VA, NC

Code Information

All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 30-Sep-15, b) 25-Sep-15